Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage

被引:55
作者
Berger, M
Stahl, N
Del Sal, G
Haupt, Y
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
[2] Lab Nazl CIB, I-34023 Trieste, Italy
[3] Dipartimento Biochim Biofis Chim Macromol, I-34023 Trieste, Italy
关键词
D O I
10.1128/MCB.25.13.5380-5388.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppression by the p53 protein largely depends on the elimination of damaged cells by apoptosis. Mutations in the polyproline region (PPR) of p53 impair its apoptotic function. Deletion of the PPR renders p53 more sensitive to inhibition by Mdm2 via an unknown mechanism. We have explored the mechanism by which the PPR modulates the p53/Mdm2 loop. Proline 82 of p53 was identified to be essential for its interaction with the checkpoint kinase 2 (Chk2) and consequent phosphorylation of p53 on serine 20, following DNA damage. These physical and functional interactions are regulated by Pint through cis-trans isomerization of proline 82. Our study unravels the pathway by which Pint activates p53 in response to DNA damage and explains how Pin1 protects p53 from Mdm2. Further, we propose a role for Pin1-dependent induction of p53 conformational change as a mechanism responsible for the enhanced interaction between p53 and Chk2 following DNA damage. Importantly, our findings elucidate the selection for mutations in the Pin1 target Thr81/Pro82 motif within the PPR of p53 in human cancer.
引用
收藏
页码:5380 / 5388
页数:9
相关论文
共 31 条
  • [1] The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells
    Baptiste, N
    Friedlander, P
    Chen, XB
    Prives, C
    [J]. ONCOGENE, 2002, 21 (01) : 9 - 21
  • [2] Chk1 and Chk2 kinases in checkpoint control and cancer
    Bartek, J
    Lukas, J
    [J]. CANCER CELL, 2003, 3 (05) : 421 - 429
  • [3] A role for the polyproline domain of p53 in its regulation by Mdm2
    Berger, M
    Sionov, RV
    Levine, AJ
    Haupt, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) : 3785 - 3790
  • [4] Chehab NH, 2000, GENE DEV, V14, P278
  • [5] Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage
    Chehab, NH
    Malikzay, A
    Stavridi, ES
    Halazonetis, TD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) : 13777 - 13782
  • [6] Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
    Chipuk, JE
    Kuwana, T
    Bouchier-Hayes, L
    Droin, NM
    Newmeyer, D
    Schuler, M
    Green, DR
    [J]. SCIENCE, 2004, 303 (5660) : 1010 - 1014
  • [7] Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain
    Craig, A
    Scott, M
    Burch, L
    Smith, G
    Ball, K
    Hupp, T
    [J]. EMBO REPORTS, 2003, 4 (08) : 787 - 792
  • [8] The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1
    Crenshaw, DG
    Yang, J
    Means, AR
    Kornbluth, S
    [J]. EMBO JOURNAL, 1998, 17 (05) : 1315 - 1327
  • [9] The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions
    Edwards, SJ
    Hananeia, L
    Eccles, MR
    Zhang, YF
    Braithwaite, AW
    [J]. ONCOGENE, 2003, 22 (29) : 4517 - 4523
  • [10] Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway
    Falck, J
    Lukas, C
    Protopopova, M
    Lukas, J
    Selivanova, G
    Bartek, J
    [J]. ONCOGENE, 2001, 20 (39) : 5503 - 5510